<DOC>
	<DOC>NCT02454387</DOC>
	<brief_summary>A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacology of ONO-4474 in healthy volunteers.</brief_summary>
	<brief_title>A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacology of ONO-4474 in Healthy Volunteers</brief_title>
	<detailed_description>A Double-blind, Multi-centre, Single Dose, Single and Multiple Ascending Dose, Four-part, Randomised, Placebo-controlled Study in Healthy Adult and Elderly Subjects Exploring the Safety, Tolerability, Pharmacokinetics of ONO-4474 in Fed and Fasted Conditions, and Pharmacology of ONO-4474 in NGF-hyperalgesia.</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>1. Healthy male subjects aged 1855 years inclusive (Parts A and C); healthy male and female subjects aged 1855 years inclusive (Part B); healthy male and female subjects aged 65 and over (Part D) 2. Subjects with a body mass index of 18.030.0 kg/m2 inclusive 1. Subjects who have a clinically relevant history or presence of any clinically significant disease or disorder 2. Current smokers or those that have smoked or used nicotine products within 6 months of the Screening visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>